COMMUNIQUÉS West-GlobeNewswire

New Phase 1 Data Show VNA-318 Mechanism of Action Translates to Humans, Supporting Potential to Address Medical Needs of People with Neurodegenerative Diseases
13/07/2026
Pharmacodynamic effects in the human brain and energy metabolism biomarker data presented at AAIC support further clinical development of VNA-318 in Alzheimer’s disease LAUSANNE, Switzerland, July 13, 2026 – Vandria, a [...]
Oxford Brain Diagnostics Advances Vision for Measuring Brain Health and Neurodegenerative Disease with Five New Studies at AAIC 2026
13/07/2026
New findings demonstrate the potential of OBD's MRI-based Cortical Disarray Measurement (CDM®) technology to support patient identification, disease characterization, treatment monitoring, and therapeutic development [...]
SCENESSE® approved for EPP in Canada
13/07/2026
Health Canada NOC enables treatment for porphyria, metabolic disorder MELBOURNE, Australia, July 13, 2026 (GLOBE NEWSWIRE) -- CLINUVEL’s novel drug SCENESSE® (afamelanotide) has been granted a Notice of Compliance (NOC [...]
AEON Welcomes The Establishment of Dubai Longevity Authority and Next Chapter of Healthcare Innovation
13/07/2026
DUBAI, United Arab Emirates, July 13, 2026 (GLOBE NEWSWIRE) -- As one of the region's leading longevity clinic , AEON welcomes the establishment of the Dubai Longevity Authority (DLA) and its potential to accelerate [...]
Alamar Biosciences Partners with Leading Research Universities to Launch National Initiative Advancing Blood-Based Biomarkers for Neurodegenerative Diseases
13/07/2026
National-scale initiative will profile ~21,000 plasma samples from 10,000 Alzheimer’s Disease and Related Dementias (ADRD) participants using Alamar Biosciences' NULISAseq™ Neuro 220 panel. Resulting dataset will be [...]
Santhera Expands Biomedica Agreement to Extend AGAMREE® (Vamorolone) Distribution Across Central Asia and the Caucasus
13/07/2026
Pratteln, Switzerland, July 13, 2026 – Santhera Pharmaceuticals (SIX: SANN) today announces an expansion of its exclusive distribution agreement with Biomedica for AGAMREE® (vamorolone), extending the partnership to [...]
Evaxion presents new preclinical data for cytomegalovirus vaccine program EVX-V1
12/07/2026
The new data demonstrates the potential to improve control of acute infection, latency, and viral reactivation, further supporting the concept behind EVX-V1 EVX-V1 is a next-generation, multi-component vaccine program [...]
LEQEMBI® Subcutaneous Autoinjector Clinical Data Supports Similar Efficacy and Safety to IV Formulation in Early Alzheimer’s Disease Presented at the Alzheimer’s Association International Conference® (AAIC®) 2026
12/07/2026
New clinical and real-world data support a subcutaneous treatment pathway from initiation through maintenance treatment, offering dosing convenience for patients and care partners TOKYO and CAMBRIDGE, Mass., July 12, [...]
Hemab Therapeutics Presents New Clinical Data from HMB-002 in Von Willebrand Disease and Introduces HMB-003 for Heavy Menstrual Bleeding at the ISTH 2026 Congress
12/07/2026
HMB-002 clinical data demonstrate proof of mechanism, with dose-dependent, greater than or equal to 2.4-fold peak increases in Von Willebrand Factor (VWF) and Factor VIII (FVIII), normalization of peak thrombin [...]
Horse Boost Gummies For Men 2026 Launch Featuring the Viral Horse Gelatin Salt Trick Recipe Male Enhancement Support By HorseBoost
11/07/2026
Discover Horse Boost For Men, inspired by the viral Horse Gelatin Salt Trick recipe with Muira Puama, Maca, Ashwagandha, and L-Arginine New Horse Boost Gummies Male Health Performance. New York City, July 11, 2026 ( [...]
La Croix-Rouge canadienne met sur pied un fonds de secours pour aider les personnes touchées par les inondations au Manitoba
11/07/2026
WINNIPEG, Manitoba, 10 juill. 2026 (GLOBE NEWSWIRE) -- La Croix-Rouge canadienne a lancé le Fonds de secours : Inondations de 2026 au Manitoba pour soutenir les personnes touchées par cette catastrophe. Les dons versés [...]
Canadian Red Cross opens appeal to support people impacted by flooding in Manitoba
11/07/2026
WINNIPEG, Manitoba, July 10, 2026 (GLOBE NEWSWIRE) -- The Canadian Red Cross has launched the 2026 Manitoba Floods Appeal to provide support for those impacted by flooding in Manitoba. Donations to the Canadian Red [...]
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
10/07/2026
PALO ALTO, Calif., July 10, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a biopharmaceutical company focused on developing medicines for genetic conditions, today [...]
Context Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
10/07/2026
PHILADELPHIA, July 10, 2026 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging bispecific antibodies for solid [...]
Korro Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10/07/2026
CAMBRIDGE, Mass., July 10, 2026 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO) a biopharmaceutical company leveraging a novel oligonucleotide promoted editing of RNA (OPERA ® ) platform to develop a new [...]
LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
10/07/2026
NEW YORK, July 10, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), today announced that it has granted to Christopher Zergebel, the new Senior Vice President, [...]
VERAXA Biotech AG Appoints Carl von Halem as Interim Chief Financial Officer and Successor to Torsten Bürgermeister
10/07/2026
ZURICH, SWITZERLAND – July 10, 2026 -- VERAXA Biotech AG (NASDAQ: VRXA; “VERAXA”), an emerging leader in designing novel cancer therapies, today announced the appointment of Carl von Halem as Interim Chief Financial [...]
SoliVana Wellness Lab Celebrates 3 years in Redwood City as the Bay Area's First Dedicated Nervous System Recovery Center
10/07/2026
Founded by two former enterprise executives, SoliVana combines 16 evidence-aligned therapies across 9 private rooms to address the stress and burnout crisis in Silicon Valley's workforce Redwood City, CA, July 10, 2026 [...]
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10/07/2026
BRISBANE, Calif., July 10, 2026 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that, on July 6, 2026, the Compensation Committee of the Board of Directors (Compensation Committee) of Vera [...]

Pages